Published Year: 2023
Cardiac AI Monitoring and Diagnostics Market - A Global and Regional Analysis: Focus on Product, Typ
The global cardiac AI monitoring and diagnostics market was valued at $1,010.5 million in 2022...
Market Research Report
A quick peek into the report
Table of Contents
1.1 Market Outlook
1.1.1 Product Definition
1.1.2 Inclusion Criteria
1.1.3 Exclusion Criteria
1.1.4 Overview
1.1.4.1 Market Size and Growth Potential
2.1 Key Trends
2.1.1 Rising Number of Startups in the Market
2.1.2 Increased Awareness Regarding Preventative Measures and Personalized Treatment
2.1.3 Growing Demand for Wearable Sensors for Cardiac Monitoring Leading to Increased Adoption of AI-Enabled Solutions for Home-Based Care
2.2 Opportunity Assessment
2.3 Regulatory Framework
2.3.1 Regulatory Framework for Artificial Intelligence-Based FDA-Approved Medical Devices and Algorithms
2.3.2 Regulatory Framework in the U.S.
2.3.3 Regulatory Framework in Europe
2.3.4 Regulatory Framework in Japan
2.3.5 Regulatory Framework in China
2.3.6 Regulatory Framework in the Other Countries
2.4 Patent Analysis
2.4.1 Awaited Technological Developments
2.4.1.1 Patent Analysis (by Country)
2.4.1.2 Patent Analysis (by Year)
2.5 Business Models
2.6 Case Studies
2.6.1 Case Study 1: Ultromics Limited
2.6.1.1 The EchoGo System
2.6.1.1.1 Developement
2.6.1.1.2 Use Case and Reliability
2.6.1.2 A Success Story
2.6.1.3 Partners and Recognitions
2.6.2 Case Study 2: CorVista Health, Inc.
2.6.2.1 The CorVista System
2.6.2.2 A Success Story
2.7 Ongoing Clinical Trials
2.8 Funding Scenario
2.9 End User Perception
2.10 Entry Barriers for New Entrants
3.1 Europe Cardiac AI Monitoring and Diagnostics Market
3.1.1 Key Findings and Opportunity Assessment
3.1.2 Digital Adoption
3.1.3 Market Dynamics
3.1.3.1 Impact Analysis
3.1.4 Market Sizing and Forecast
3.1.4.1 Europe Cardiac AI Monitoring and Diagnostics Market (by Product)
3.1.4.2 Europe Cardiac AI Monitoring and Diagnostics Market (by Type)
3.1.4.2.1 Europe Cardiac AI Monitoring and Diagnostics Market
(by Cardiac Diagnostics) 76
3.1.4.3 Europe Cardiac AI Monitoring and Diagnostics Market (by Application)
3.1.4.4 Europe Cardiac AI Monitoring and Diagnostics Market (by End User)
3.1.4.5 Europe Cardiac AI Monitoring and Diagnostics Market (by Country)
3.1.4.5.1 Germany
3.1.4.5.1.1 Market Dynamics
3.1.4.5.1.2 Market Size and Forecast
3.1.4.5.1.2.1 Germany Cardiac AI Monitoring and Diagnostics Market (by Product)
3.1.4.5.1.2.2 Germany Cardiac AI Monitoring and Diagnostics Market (by Type)
3.1.4.5.1.2.2.1 Germany Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
3.1.4.5.1.2.3 Germany Cardiac AI Monitoring and Diagnostics Market (by Application)
3.1.4.5.1.2.4 Germany Cardiac AI Monitoring and Diagnostics Market (by End User)
3.1.4.5.2 U.K.
3.1.4.5.2.1 Market Dynamics
3.1.4.5.2.2 Market Size and Forecast
3.1.4.5.2.2.1 U.K. Cardiac AI Monitoring and Diagnostics Market (by Product)
3.1.4.5.2.2.2 U.K. Cardiac AI Monitoring and Diagnostics Market (by Type)
3.1.4.5.2.2.2.1 U.K. Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
3.1.4.5.2.2.3 U.K. Cardiac AI Monitoring and Diagnostics Market (by Application)
3.1.4.5.2.2.4 U.K. Cardiac AI Monitoring and Diagnostics Market (by End User)
3.1.4.5.3 France
3.1.4.5.3.1 Market Dynamics
3.1.4.5.3.2 Market Size and Forecast
3.1.4.5.3.2.1 France Cardiac AI Monitoring and Diagnostics Market (by Product)
3.1.4.5.3.2.2 France Cardiac AI Monitoring and Diagnostics Market (by Type)
3.1.4.5.3.2.2.1 France Cardiac AI Monitoring and Diagnostics Market (by Cardiac
Diagnostics) 90
3.1.4.5.3.2.3 France Cardiac AI Monitoring and Diagnostics Market (by Application)
3.1.4.5.3.2.4 France Cardiac AI Monitoring and Diagnostics Market (by End User)
3.1.4.5.4 Italy
3.1.4.5.4.1 Market Dynamics
3.1.4.5.4.2 Market Size and Forecast
3.1.4.5.4.2.1 Italy Cardiac AI Monitoring and Diagnostics Market (by Product)
3.1.4.5.4.2.2 Italy Cardiac AI Monitoring and Diagnostics Market (by Type)
3.1.4.5.4.2.2.1 Italy Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
3.1.4.5.4.2.3 Italy Cardiac AI Monitoring and Diagnostics Market (by Application)
3.1.4.5.4.2.4 Italy Cardiac AI Monitoring and Diagnostics Market (by End User)
3.1.4.5.5 Spain
3.1.4.5.5.1 Market Dynamics
3.1.4.5.5.2 Market Size and Forecast
3.1.4.5.5.2.1 Spain Cardiac AI Monitoring and Diagnostics Market (by Product)
3.1.4.5.5.2.2 Spain Cardiac AI Monitoring and Diagnostics Market (by Type)
3.1.4.5.5.2.2.1 Spain Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
3.1.4.5.5.2.3 Spain Cardiac AI Monitoring and Diagnostics Market (by Application)
3.1.4.5.5.2.4 Spain Cardiac AI Monitoring and Diagnostics Market (by End User)
3.1.4.5.6 Rest-of-Europe
3.1.4.5.6.1 Market Size and Forecast
3.1.4.5.6.1.1 Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by Product)
3.1.4.5.6.1.2 Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by Type)
3.1.4.5.6.1.2.1 Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
3.1.4.5.6.1.3 Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by Application)
3.1.4.5.6.1.4 Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by End
4.1 Cardiac AI Monitoring and Diagnostics Active Players Ecosystem
4.2 Key Strategies and Developments
4.2.1 Regulatory and Legal Activities
4.2.2 Partnerships, Alliances, and Business Expansions
4.2.3 Funding Activities
4.2.4 New Offerings
4.2.5 Mergers and Acquisitions
4.3 Company Profiles
4.3.1 Koninklijke Philips N.V.
4.3.1.1 Company Overview
4.3.1.2 Role of Koninklijke Philips N.V. in the Cardiac AI Monitoring and Diagnostics Market
4.3.1.3 Financials
4.3.1.4 Key Developments
4.3.1.5 Analyst Perception
4.3.2 Medicalgorithmics S.A.
4.3.2.1 Company Overview
4.3.2.2 Role of Medicalgorithmics S.A. in the Cardiac AI Monitoring and Diagnostics Market
4.3.2.3 Key Developments
4.3.2.4 Analyst Perception
4.3.3 Siemens Healthineers AG
4.3.3.1 Company Overview
4.3.3.2 Role of Siemens Healthineers AG in the Cardiac AI Monitoring and Diagnostics Market
4.3.3.3 Financials
4.3.3.4 Analyst Perception
4.3.4 Ultromics Limited.
4.3.4.1 Company Overview
4.3.4.2 Role of Ultromics Limited. in the Cardiac AI Monitoring and Diagnostics Market
4.3.4.3 Key Developments
4.3.4.4 Analyst Perception
Table 1: Regulatory Framework
Table 2: Key Questions Answered in the Report
Table 3: Startups Entering the Market
Table 4: Regulatory Framework of Different Countries
Table 5: Cardiac AI Monitoring and Diagnostics Market, Awaited Technological Developments
Table 6: CorVista Health Inc. Publications
Table 7: Cardiac AI Monitoring and Diagnostics Market, Ongoing Clinical Trials
Table 8: Investments and Fundings in Cardiac AI Monitoring and Diagnostics Market
Table 9: Europe Cardiac AI Monitoring and Diagnostics Market, Impact Analysis
Table 10: Cardiac AI Monitoring and Diagnostics Active Players Ecosystem
Figure 1: AI in Cardiac Monitoring and Diagnosis
Figure 2: Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 3: Cardiac AI Monitoring and Diagnostics Market, Market Dynamics
Figure 4: Key Trends in the Cardiac AI Monitoring and Diagnostics Market
Figure 5: Entry Barriers for New Entrants
Figure 6: Cardiac AI Monitoring and Diagnostics Market Share (by Product), 2022 and 2032
Figure 7: Cardiac AI Monitoring and Diagnostics Market Share (by Type), 2022 and 2032
Figure 8: Cardiac AI Monitoring and Diagnostics Market Share (by Application), 2022 and 2032
Figure 9: Cardiac AI Monitoring and Diagnostics Market Share (by End Users), 2022 and 2032
Figure 10: Cardiac AI Monitoring and Diagnostics Market (by Region), $Million, 2022
Figure 11: Key Developments and Strategies Analysis, January 2020-June 2023
Figure 12: Cardiac AI Monitoring and Diagnostics Market: Research Methodology
Figure 13: Primary Research Methodology
Figure 14: Bottom-Up Approach (Segment-Wise Analysis)
Figure 15: Top-Down Approach (Segment-Wise Analysis)
Figure 16: Overview of the Role of AI in Cardiology
Figure 17: Cardiac AI Monitoring and Diagnostics Market, Size and Growth Potential, $Million, 2022-2032
Figure 18: Cardiac AI Monitoring and Diagnostics Market, Key Trends
Figure 19: Potential of AI for Processing Patient's Own Data
Figure 20: Advantages of AI-Enabled Wearable Sensors for Cardiac Monitoring
Figure 21: Cardiac AI Monitoring and Diagnostics Market, Key Trends, Opportunity Assessment, 2023-2032
Figure 22: Regulatory Process for Medical Devices in the U.S.
Figure 23: Cardiac AI Monitoring and Diagnostics Market, Patent Analysis (by Country), January 2018-June 2023
Figure 24: Cardiac AI Monitoring and Diagnostics Market, Patent Analysis (by Year), January 2018-June 2023
Figure 25: Different Types of Business Models in the AI in Healthcare Scenario
Figure 26: Subscription-Based Model the Market is Shifting Towards
Figure 27: Partners of Ultromics Limited
Figure 28: Ultromics Limited:Awards and Recognitions
Figure 29: The CorVista System
Figure 30: Cardiac AI Monitoring and Diagnostics Market, Quarterly Analysis of Funding Scenario, January 2020-June 2023
Figure 31: Cardiac AI Monitoring and Diagnostics Market, End User Perceptions
Figure 32: Entry Barriers for New Entrants
Figure 33: Recommendations to Tackle the Entry Barriers
Figure 34: Cardiac AI Monitoring and Diagnostics Market Share (by Region), 2022-2032
Figure 35: Europe Cardiac AI Monitoring and Diagnostics Market, Incremental Opportunity (by Country), $Million, 2023-2032
Figure 36: Digital Competence Framework for Citizens Developed by the European Commission
Figure 37: Europe Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 38: Europe Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 39: Europe Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 40: Europe Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 41: Europe Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 42: Europe Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 43: Europe Cardiac AI Monitoring and Diagnostics Market (by Country), % Share, 2022 and 2032
Figure 44: Germany Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 45: Germany Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 46: Germany Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 47: Germany Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 48: Germany Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 49: Germany Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 50: U.K. Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 51: U.K. Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 52: U.K. Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 53: U.K. Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 54: U.K. Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 55: U.K. Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 56: France Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 57: France Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 58: France Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 59: France Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 60: France Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 61: France Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 62: Italy Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 63: Italy Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 64: Italy Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 65: Italy Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 66: Italy Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 67: Italy Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 68: Spain Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 69: Spain Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 70: Spain Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 71: Spain Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 72: Spain Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 73: Spain Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 74: Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 75: Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 76: Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 77: Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 78: Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 79: Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 80: Share of Key Developments and Strategies, January 2019-June 2023
Figure 81: Regulatory and Legal Activities (by Company), January 2019-June 2023
Figure 82: Partnerships, Alliances, and Business Expansions (by Company), January 2019-June 2023
Figure 83: Funding Activities (by Company), January 2019-June 2023
Figure 84: New Offerings (by Company), January 2019-June 2023
Figure 85: Mergers and Acquisitions (by Company), January 2019-June 2023
Figure 86: Koninklijke Philips N.V.: Overall Product Portfolio
Figure 87: Koninklijke Philips N.V.: Overall Financials, $Million, 2020-2022
Figure 88: Koninklijke Philips N.V.: Net Revenue (by Segment), $Million, 2020-2022
Figure 89: Koninklijke Philips N.V.: Revenue (by Region), $Million, 2020-2022
Figure 90: Koninklijke Philips N.V.: R&D Expenditure, $Million, 2022-2022
Figure 91: Medicalgorithmics S.A.: Overall Product Portfolio
Figure 92: Siemens Healthineers AG: Overall Product Portfolio
Figure 93: Siemens Healthineers AG: Overall Financials, $Million, 2020-2022
Figure 94: Siemens Healthineers AG: Net Revenue (by Segment), $Million, 2020-2022
Figure 95: Siemens Healthineers AG: Net Revenue (by Region), $Million, 2020-2022
Figure 96: Siemens Healthineers AG: R&D Expenditure, $Million, 2020-2022
Figure 97: Ultromics Limited.: Overall Product Portfolio
Europe Cardiac AI Monitoring and Diagnostics Market Report Coverage
|
Europe Cardiac AI Monitoring and Diagnostics Market |
|||
|
Base Year |
2022 |
Market Size in 2022 |
$275.6 Million |
|
Forecast Period |
2023-2032 |
Value Projection and Estimation by 2032 |
$3,199.9 Million |
|
CAGR During Forecast Period |
28.09% |
|
|
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analysing company coverage, product portfolio, and market penetration.
Some of the prominent names established in this market are:
• Koninklijke Philips N.V.
• Medicalgorithmics S.A.
• Siemens Healthineers AG
• Ultromics Limited.
How Can This Report Add Value to an Organization?
Product/Innovation Strategy: The Europe cardiac AI monitoring and diagnostics market has been extensively segmented based on various categories, such as products, types, applications, and end users. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.
Introduction to Europe Cardiac AI Monitoring and Diagnostics Market
The Europe cardiac AI monitoring and diagnostics market was valued at $275.6 million in 2022 and is anticipated to reach $3,199.9 million by 2032, witnessing a CAGR of 28.09% during the forecast period 2023-2032. The high prevalence of cardiovascular diseases worldwide, rising government initiatives for AI adoption, expanding research in the field of AI for cardiology, rising regulatory approvals of cardiac diagnostics AI medical devices, and technological advancements in the field of cardiac AI diagnostics are the main factors propelling the growth of the europe market for cardiac AI monitoring and diagnostics.
Market Introduction
The market for cardiac AI monitoring and diagnostics in Europe has grown and advanced significantly in recent years. Cardiologists are using artificial intelligence (AI) technology more and more to improve diagnoses and monitoring for a range of heart diseases.
Vast volumes of patient data, like as electrocardiograms (ECGs), imaging scans, and patient histories, can be analyzed by AI-powered cardiac monitoring systems in order to find and identify anomalies or possible cardiac diseases. These technologies can enhance patient outcomes, offer prompt and accurate diagnoses, and support healthcare personnel in making decisions by utilizing AI algorithms and machine learning.
There are many benefits of using AI in cardiac monitoring and diagnostics. It makes patient data analysis more thorough and efficient, which helps identify cardiac problems early on, which is essential for prompt intervention and treatment. In addition, AI algorithms can help with risk management and stratification by locating high-risk patients and enhancing treatment regimens.
Furthermore, telehealth applications in the field of cardiology and remote monitoring are made possible by AI technology. AI-enabled wearables and sensors can send real-time data to healthcare providers while continuously monitoring a patient's heart parameters. This enhances patient access to care and lowers healthcare costs by enabling remote management of chronic illnesses, early detection of arrhythmias or cardiac events, and remote monitoring of high-risk patients.
Technology businesses, healthcare providers, and research organizations are investing heavily and collaborating in the European cardiac AI monitoring and diagnostics industry. A favorable regulatory environment, rising cardiovascular disease prevalence, and growing demand for sophisticated cardiac monitoring and diagnostics are propelling the market expansion in the area.
But there are still issues to be resolved, like worries about data security and privacy, a lack of compatibility between various AI systems, and the requirement for thorough assessment and legal clearance of AI algorithms. Standardized methods and recommendations for the application of AI in cardiac monitoring and diagnostics are being developed in order to guarantee patient safety and encourage broad adoption among European nations.
Market Segmentation:
Segmentation 1: by Product
• Software
• Hardware
Segmentation 2: by Type
• Cardiac Diagnostics
o Imaging
o ECG-Based
o Others
• Cardiac Monitoring
Segmentation 3: by Application
• Ischemic Heart Disease/CAD
• Cardiac Arrhythmias
• Ischemic Stroke
• Others
Segmentation 4: by End User
• Hospitals
• Diagnostic Centers
• Other End Users
Segmentation 5: by Country
• Germany
• U.K.
• France
• Spain
• Italy
• Rest-of-Europe
Europe Cardiac AI Monitoring and Diagnostics Market
Analysis and Forecast, 2023-2032
Similar Product
You may also like